Alcohol Screening Program with Biomarkers for HIV-affected Youth in Zambia
Screening, brief intervention, and referral to treatment (SBIRT)
Diagnostic Study
Summary
Study start date: August 1, 2025
Actual date on which the first participant was enrolled.This study is exploring a new program to screen and help young people in Zambia who are affected by HIV and might also be consuming alcohol. It's important because alcohol use can negatively affect HIV treatment and prevention efforts. The program uses a combination of self-reported information and a urine test to check for recent alcohol use. The main goal is to see how well the program can be integrated into existing HIV services and whether it helps reduce alcohol consumption among adolescents and young adults in Lusaka, Zambia. This is crucial as it could improve overall health outcomes for these individuals. Participants will be involved in different parts of the study, starting with a screening for recent alcohol use. If alcohol use is detected, they will receive a brief intervention to discuss their drinking habits and might be referred for further treatment if needed. The study will track how many participants go through each step of this process and will also collect feedback from the participants and staff through interviews. The study will look at how well the program is working and if it helps reduce alcohol use over time. It's a pilot, so any risks or benefits are still being evaluated, but the study aims to help improve the care and support for young people dealing with both HIV and alcohol use issues.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Diagnostic Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 16 to 24 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: * 16-24 years of age * Residing in Lusaka, Zambia * Meets definition of HIV-affected as evidenced as being involved in HIV testing and treatment and Adolescent Friendly Spaces Programs at the three sites (we will not ask adolescents direct questions about HIV during screening; see Recruitment section). Exclusion Criteria: • Unable or unwilling to provide informed assent/consent
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives